Literature DB >> 33536596

An epigenetic tipping point in cancer comes under the microscope.

Martyna W Sroka, Christopher R Vakoc.   

Abstract

Entities:  

Keywords:  Cancer; Epigenetics

Year:  2021        PMID： 33536596     DOI： 10.1038/d41586-021-00002-5

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.

Authors:  Catherine C Fahey; Ian J Davis
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

2.  Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.

Authors:  Simon Papillon-Cavanagh; Chao Lu; Tenzin Gayden; Leonie G Mikael; Denise Bechet; Christina Karamboulas; Laurie Ailles; Jason Karamchandani; Dylan M Marchione; Benjamin A Garcia; Ilan Weinreb; David Goldstein; Peter W Lewis; Octavia Maria Dancu; Sandeep Dhaliwal; William Stecho; Christopher J Howlett; Joe S Mymryk; John W Barrett; Anthony C Nichols; C David Allis; Jacek Majewski; Nada Jabado
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 38.330

3.  Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.

Authors:  Chao Lu; Siddhant U Jain; Dominik Hoelper; Denise Bechet; Rosalynn C Molden; Leili Ran; Devan Murphy; Sriram Venneti; Meera Hameed; Bruce R Pawel; Jay S Wunder; Brendan C Dickson; Stefan M Lundgren; Krupa S Jani; Nicolas De Jay; Simon Papillon-Cavanagh; Irene L Andrulis; Sarah L Sawyer; David Grynspan; Robert E Turcotte; Javad Nadaf; Somayyeh Fahiminiyah; Tom W Muir; Jacek Majewski; Craig B Thompson; Ping Chi; Benjamin A Garcia; C David Allis; Nada Jabado; Peter W Lewis
Journal:  Science       Date:  2016-05-13       Impact factor: 47.728

4.  NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

Authors:  Alex J Kuo; Peggie Cheung; Kaifu Chen; Barry M Zee; Mitomu Kioi; Josh Lauring; Yuanxin Xi; Ben Ho Park; Xiaobing Shi; Benjamin A Garcia; Wei Li; Or Gozani
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 17.970

5.  NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

Authors:  Gang G Wang; Ling Cai; Martina P Pasillas; Mark P Kamps
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

6.  Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.

Authors:  Relja Popovic; Eva Martinez-Garcia; Eugenia G Giannopoulou; Quanwei Zhang; Qingyang Zhang; Teresa Ezponda; Mrinal Y Shah; Yupeng Zheng; Christine M Will; Eliza C Small; Youjia Hua; Marinka Bulic; Yanwen Jiang; Matteo Carrara; Raffaele A Calogero; William L Kath; Neil L Kelleher; Ji-Ping Wang; Olivier Elemento; Jonathan D Licht
Journal:  PLoS Genet       Date:  2014-09-04       Impact factor: 5.917

7.  The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate.

Authors:  Yan Li; Patrick Trojer; Chong-Feng Xu; Peggie Cheung; Alex Kuo; William J Drury; Qi Qiao; Thomas A Neubert; Rui-Ming Xu; Or Gozani; Danny Reinberg
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

8.  Covalent inhibition of NSD1 histone methyltransferase.

Authors:  Huang Huang; Christina A Howard; Sergei Zari; Hyo Je Cho; Shirish Shukla; Hao Li; Juliano Ndoj; Paula González-Alonso; Caroline Nikolaidis; Joshua Abbott; David S Rogawski; Mykhaylo A Potopnyk; Katarzyna Kempinska; Hongzhi Miao; Trupta Purohit; Andrew Henderson; Anna Mapp; Maria Luisa Sulis; Adolfo Ferrando; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2020-08-31       Impact factor: 15.040
  8 in total
  2 in total

1.  Computational Study of Methionine Methylation Process Catalyzed by SETD3.

Authors:  Yuan-Yuan Zhao; Hao Deng; Adua Rahman; Xiao-Long Xu; Ping Qian; Hong Guo
Journal:  Interdiscip Sci       Date:  2022-04-13       Impact factor: 3.492

Review 2.  Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.

Authors:  Zhenyi Niu; Runsen Jin; Yan Zhang; Hecheng Li
Journal:  Signal Transduct Target Ther       Date:  2022-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.